These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8761884)

  • 1. Teratogenic potential of almokalant, dofetilide, and d-sotalol: drugs with potassium channel blocking activity.
    Webster WS; Brown-Woodman PD; Snow MD; Danielsson BR
    Teratology; 1996 Mar; 53(3):168-75. PubMed ID: 8761884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The teratogenic effect of dofetilide during rat limb development and association with drug-induced bradycardia and hypoxia in the embryo.
    Ritchie HE; Ababneh DH; Oakes DJ; Power CA; Webster WS
    Birth Defects Res B Dev Reprod Toxicol; 2013 Apr; 98(2):144-53. PubMed ID: 23504928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teratogenicity by the hERG potassium channel blocking drug almokalant: use of hypoxia marker gives evidence for a hypoxia-related mechanism mediated via embryonic arrhythmia.
    Danielsson BR; Sköld AC; Johansson A; Dillner B; Blomgren B
    Toxicol Appl Pharmacol; 2003 Dec; 193(2):168-76. PubMed ID: 14644619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of rhythm abnormalities in the fetal rat heart. A tentative mechanism for the embryotoxic effect of the class III antiarrhythmic agent almokalant.
    Abrahamsson C; Palmer M; Ljung B; Duker G; Bäärnhielm C; Carlsson L; Danielsson B
    Cardiovasc Res; 1994 Mar; 28(3):337-44. PubMed ID: 8174153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the class III antiarrhythmic, dofetilide (UK-68,798) on the heart rate of midgestation rat embryos, in vitro.
    Spence SG; Vetter C; Hoe CM
    Teratology; 1994 Apr; 49(4):282-92. PubMed ID: 8073367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryonic cardiac arrhythmia and generation of reactive oxygen species: common teratogenic mechanism for IKr blocking drugs.
    Danielsson BR; Danielsson C; Nilsson MF
    Reprod Toxicol; 2007 Jul; 24(1):42-56. PubMed ID: 17570632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect on rat embryonic heart rate of Na+, K+, and Ca2+ channel blockers, and the human teratogen phenytoin, changes with gestational age.
    Nilsson MF; Ritchie H; Webster WS
    Birth Defects Res B Dev Reprod Toxicol; 2013 Oct; 98(5):416-27. PubMed ID: 24323366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage-specific skeletal and visceral defects of the I(Kr)-blocker almokalant: further evidence for teratogenicity via a hypoxia-related mechanism.
    Sköld AC; Wellfelt K; Danielsson BR
    Teratology; 2001 Dec; 64(6):292-300. PubMed ID: 11754171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin-induced cleft palate: evidence for embryonic cardiac bradyarrhythmia due to inhibition of delayed rectifier K+ channels resulting in hypoxia-reoxygenation damage.
    Azarbayjani F; Danielsson BR
    Teratology; 2001 Mar; 63(3):152-60. PubMed ID: 11283972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of hypoxia in development.
    Webster WS; Abela D
    Birth Defects Res C Embryo Today; 2007 Sep; 81(3):215-28. PubMed ID: 17963271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New proposals for testing drugs with IKr-blocking activity to determine their teratogenic potential.
    Karlsson M; Danielsson BR; Nilsson MF; Danielsson C; Webster WS
    Curr Pharm Des; 2007; 13(29):2979-88. PubMed ID: 17979741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental toxicity of the class III antiarrhythmic agent almokalant in mice. Adverse effects mediated via induction of embryonic heart rhythm abnormalities.
    Sköld AC; Danielsson BR
    Arzneimittelforschung; 2000 Jun; 50(6):520-5. PubMed ID: 10918943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental toxicity in the pregnant rabbit by the class III antiarrhythmic drug sotalol.
    Sköld AC; Danielsson BR
    Pharmacol Toxicol; 2001 Jan; 88(1):34-9. PubMed ID: 11169159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Dofetilide on the Heart Rate of GD11 and GD13 Rat Embryos, in vivo, Using Ultrasound.
    Ritchie H; Oakes D; Hung TT; Hegedus E; Sood S; Webster W
    Birth Defects Res B Dev Reprod Toxicol; 2015 Oct; 104(5):196-203. PubMed ID: 26401846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of increased extracellular potassium and pacing frequency on the class III activities of methanesulfonanilide IKr blockers dofetilide, D-sotalol, E-4031, and MK-499.
    Baskin EP; Lynch JJ
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):199-208. PubMed ID: 7526051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embryonic arrhythmia by inhibition of HERG channels: a common hypoxia-related teratogenic mechanism for antiepileptic drugs?
    Azarbayjani F; Danielsson BR
    Epilepsia; 2002 May; 43(5):457-68. PubMed ID: 12027905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of EGIS-7229 (S 21407), a novel class III antiarrhythmic drug, on myocardial refractoriness to electrical stimulation in vivo and in vitro.
    Kovács A; Gyönös I; Magyar J; Bányász T; Nánási PP; Spedding M; Szénási G
    J Cardiovasc Pharmacol; 2001 Jan; 37(1):78-88. PubMed ID: 11152377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class III antiarrhythmics and phenytoin: teratogenicity due to embryonic cardiac dysrhythmia and reoxygenation damage.
    Danielsson BR; Skold AC; Azarbayjani F
    Curr Pharm Des; 2001 Jun; 7(9):787-802. PubMed ID: 11375779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved methodology for identifying the teratogenic potential in early drug development of hERG channel blocking drugs.
    Nilsson MF; Danielsson C; Sköld AC; Johansson A; Blomgren B; Wilson J; Khan KM; Bengtsson E; Kultima K; Webster WS; Danielsson BR
    Reprod Toxicol; 2010 Apr; 29(2):156-63. PubMed ID: 20144703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embryotoxic effects of L-691,121, a class III antiarrhythmic agent, in rats.
    Ban Y; Konishi R; Kawana K; Nakatsuka T; Fujii T; Manson JM
    Arch Toxicol; 1994; 69(1):65-71. PubMed ID: 7717857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.